Category: Gene Therapy
Global Gene Therapy
-
Viral Vector Production Market Size, Trends, Analysis, and Outlook By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology), By Viral Vector (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Production market size is poised to register 17.68% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Cancer Biological Therapy Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Cancer growth Blockers, Monoclonal Antibodies, Blood Cell Growth Factors, Gene Therapy), By Cancer (Pancreatic Cancer, Lung Cancer, Blood Cancer, Colorectal Cancer, Others), By Distribution Channel (Specialized cancer treatment centers, Hospitals Pharmacies, Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Specialized cancer treatment centers, Hospitals Pharmacies, Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Cancer Biological Therapy market size is poised to register 7.88% growth from 2024 to 2030, presenting ... Read More
-
Viral Vectors and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others), By Manufacturing (Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting), Downstream Manufacturing (Purification, Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, ... Read More
-
Advanced Therapy Medicinal Products Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Stem Cell Therapy, Non-stem Cell Therapy, Gene Therapy, Tissue Engineered Product), by Region, Country, Segment, and Companies, 2024-2030
... Therapy Medicinal Products market size is poised to register 16.69% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Advanced Therapy Medicinal Products ... Read More
-
Cell and Gene Therapy Bioanalytical Testing Services Market Size, Trends, Analysis, and Outlook By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Others), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage Of Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy Bioanalytical Testing Services market size is poised to register ... Read More
-
Cancer Gene Therapy Market Size, Trends, Analysis, and Outlook By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), By End-User (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Cancer Gene Therapy market size is poised to register 20.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Gene Therapy ... Read More
-
Serum-free Media Market Size, Trends, Analysis, and Outlook By Product (Classical Media, Specialty Media, Stem Cell Media, Others), By End-user (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Others), By Application (Bioproduction, Vaccine Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030
... Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
-
Viral Vector Contract Development Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Vector (Adenovirus, Retrovirus, Adeno-Associated Virus, Lentivirus, Others), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Antisense & RNAi Therapy, Gene Therapy-, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Contract Development Manufacturing Organizations market size is poised to register 14.5% growth ... Read More
-
Primary Cell Culture Market Size, Trends, Analysis, and Outlook By Product (Primary Cells, Reagents and Supplements, Media), By Separation Method (Explant Method, Enzymatic Degradation, Mechanical Separation, Others), By Type (Animal Cells, Human Cells), By Application (Cell & Gene Therapy Development, Vaccine Production, Model System, Virology, Prenatal Diagnosis, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Cell & Gene Therapy Development, Vaccine Production, Model System, Virology, Prenatal Diagnosis, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Primary Cell Culture market size is poised to register 12.97% growth from 2024 ... Read More
-
Spinal Muscular Atrophy Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Gene Therapy, Drug), By Drug (Spinraza, Zolgensma, Evrysdi, Others), By Route of Administration (Oral, Injection), by Region, Country, Segment, and Companies, 2024-2030
... global Spinal Muscular Atrophy Treatment market size is poised to register 13.62% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Spinal Muscular ... Read More
-
Adeno Associated Virus Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Scale of Operations (Clinical, Preclinical, Commercial), By Therapeutic Area (Hematological Diseases, Infectious Diseases, Genetic Disorders, Neurological Disorders, Ophthalmic Disorders, Others), By Application (Cell Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030 The global Adeno Associated Virus Vector Manufacturing market size is poised to register 23.77% growth from 2024 to ... Read More
-
Advanced Therapy Medicinal Products CDMO Market Size, Trends, Analysis, and Outlook By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, Central nervous system, Musculoskeletal, Infectious disease, Dermatology, Endocrine, metabolic, genetic, Immunology & inflammation, Ophthalmology, Hematology, Gastroenterology, Others), by Region, Country, Segment, and Companies, 2024-2030
... nervous system, Musculoskeletal, Infectious disease, Dermatology, Endocrine, metabolic, genetic, Immunology & inflammation, Ophthalmology, Hematology, Gastroenterology, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Advanced Therapy Medicinal Products CDMO market size is poised to ... Read More
-
Virtual 3D Nanorobots Market Size, Trends, Analysis, and Outlook By Type (Microbivore Nanorobots, Respirocyte Nanorobots, Clottocyte Nanorobots ), By Application (Dentistry, Brain Aneurysm, Cancer Detection And Treatment, Gene Therapy, Surgery, Nanomedicine), By Technique (Biochips, Nubots, Surface-bound Systems, Biohybrids, 3D Printing, Others), by Region, Country, Segment, and Companies, 2024-2030
... Surface-bound Systems, Biohybrids, 3D Printing, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Virtual 3D Nanorobots market size is poised to register 11.22% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
AAV Contract Development and Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Workflow (Upstream Processing, Downstream Processing), By Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global AAV Contract Development and Manufacturing Organizations market size is poised to register ... Read More
-
The 2025-2030 World Outlook for Expression Vectors
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Genetic Modification Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Gene Therapies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Cancer Gene Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Viral Inactivation Kits and Reagents
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Viral Vector and Plasmaid DNA
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Viral Vector and Plasmid DNA Technologies
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Gene Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hemophilia Gene Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Lentivirus Gene Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
Research Assistance
